Trevi Therapeutics, Inc. (TRVI): Price and Financial Metrics


Trevi Therapeutics, Inc. (TRVI)

Today's Latest Price: $5.20 USD

0.04 (0.78%)

Updated Feb 18 8:00pm

Add TRVI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

TRVI Daily Price Range
TRVI 52-Week Price Range

TRVI Stock Price Chart More Charts


TRVI Price/Volume Stats

Current price $5.20 52-week high $10.62
Prev. close $5.16 52-week low $2.65
Day low $5.15 Volume 1,700
Day high $5.38 Avg. volume 9,423
50-day MA $4.50 Dividend yield N/A
200-day MA $0.00 Market Cap 92.74M

Trevi Therapeutics, Inc. (TRVI) Company Bio


Trevi Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of treatment for neurologically mediated conditions. It focuses on the formulation of nalbuphine ER, which use to treat chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good on March 17, 2011 and is headquartered in New Haven, CT.


TRVI Latest News Stream


Event/TimeNews Detail
Loading, please wait...

TRVI Latest Social Stream


Loading social stream, please wait...

View Full TRVI Social Stream

TRVI Price Returns

1-mo N/A
3-mo 22.35%
6-mo 8.33%
1-year N/A
3-year N/A
5-year N/A
YTD 38.67%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5952 seconds.